These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19095376)

  • 1. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment.
    Schwartz DL; Lobo MJ; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Evans DB; Clayman G; Sherman SI; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1083-91. PubMed ID: 19095376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
    Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of differentiated thyroid carcinoma studied in 500 patients.
    Lerch H; Schober O; Kuwert T; Saur HB
    J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
    Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
    Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse].
    Compagnon F; Zerdoud S; Rives M; Laprie A; Sarini J; Grunenwald S; Chaltiel L; Graff P
    Cancer Radiother; 2016 Jul; 20(5):362-9. PubMed ID: 27396902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital.
    O'Connell ME; A'Hern RP; Harmer CL
    Eur J Cancer; 1994; 30A(6):733-9. PubMed ID: 7917529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma.
    Lin JD; Tsang NM; Huang MJ; Weng HF
    Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
    Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
    Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea.
    Keum KC; Suh YG; Koom WS; Cho JH; Shim SJ; Lee CG; Park CS; Chung WY; Kim GE
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):474-80. PubMed ID: 16542796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated thyroid cancer: prognostic factors and influence of treatment on the outcome in 441 patients.
    Sautter-Bihl ML; Raub J; Hetzel-Sesterheim M; Heinze HG
    Strahlenther Onkol; 2001 Mar; 177(3):125-31. PubMed ID: 11285769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
    Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
    Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
    So K; Smith RE; Davis SR
    ANZ J Surg; 2016 Sep; 86(9):696-700. PubMed ID: 26573999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
    Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
    Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy.
    Shugard E; Chen J; Quivey JM; Glastonbury CM; Khanafshar E; Garsa AA; George JR; Yom SS
    J Med Imaging Radiat Oncol; 2016 Aug; 60(4):560-7. PubMed ID: 27020481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.